Bart de Taeye

Bart De Taeye is an experienced professional specializing in life sciences and investment management. Currently serving as a Board Observer at Confo Therapeutics and as a Member of the Board of Directors for several companies including Augustine Therapeutics and AstriVax, Bart De Taeye also holds the position of Senior Investment Manager for Life Sciences & Care at PMV. With a notable career that includes roles such as Senior Business Development Manager at VIB and various leadership positions in drug discovery at CISTIM and reMYND NV, Bart De Taeye has demonstrated expertise in connecting innovative science with business strategies. Bart De Taeye holds a PhD in Pharmaceutical Biology, a postgraduate degree in Business Economics, and a degree in Pharmaceutical Sciences, all from KU Leuven.